TY - JOUR
T1 - Mindfulness-Based Cognitive Therapy for Preventing Suicide in Military Veterans
T2 - A Randomized Clinical Trial
AU - Interian, Alejandro
AU - Chesin, Megan S.
AU - Stanley, Barbara
AU - Latorre, Miriam
AU - St. Hill, Lauren M.
AU - Miller, Rachael B.
AU - King, Arlene R.
AU - Boschulte, Dianna R.
AU - Rodriguez, Kailyn M.
AU - Kline, Anna
N1 - Funding Information:
Submitted: November 17, 2020; accepted March 9, 2021. Published online: August 31, 2021. Potential conflicts of interest: Dr Stanley receives royalties from the Research Foundation for Mental Hygiene for the commercial use of the C-SSRS. Drs Interian, Chesin, Latorre, King, Boschulte, and Kline and Mss St. Hill, Miller, and Rodriguez have no conflicts to disclose. Funding/support: This project was supported by a grant from the U.S. Department of Veterans Affairs, Health Services Research and Development Service (IIR 12-134). This material is the result of work supported with resources and the use of facilities at the VA New Jersey Healthcare System. Role of the sponsor: The study sponsor had no role in the design, analysis, interpretation, or publication of this study. Disclaimer: The contents of this article do not represent the views of the US Department of Veterans Affairs or the United States Government. Supplementary material: Available at PSYCHIATRIST.COM
Publisher Copyright:
Copyright © 2021 Physicians Postgraduate Press, Inc.
PY - 2021/9
Y1 - 2021/9
N2 - Objective: This study evaluated whether Mindfulness-Based Cognitive Therapy for Preventing Suicide Behavior (MBCT-S) effectively augmented treatment-as-usual enhanced for suicide prevention (eTAU). Methods: From December 2013 through March 2018, veterans (N = 140) at high risk for suicide were recruited mostly (88.6%) during a suicide-related inpatient admission and randomly assigned to either (1) eTAU augmented with MBCT-S or (2) eTAU only. MBCT-S began during inpatient treatment (2 individual sessions emphasizing safety planning) and continued post-discharge (8 group sessions emphasizing mindfulness skills and elaborated safety planning). Four follow-up evaluations occurred over 12 months, and primary outcomes were (1) time to suicide event and (2) number of suicide events. Secondary outcomes were time to and number of suicide attempts, proportion with acute psychiatric hospitalization, and change in suicide-related factors (eg, depression, hopelessness, suicidal ideation). Results: Relative to eTAU, MBCT-S did not significantly delay time to suicide event (hazard ratio = 0.86; 95% CI, 0.52-1.41; P = .54), but did reduce total number of suicide events (MBCT-S: 56 events; eTAU: 92 events; incident rate ratio = 0.59; 95% CI, 0.36-0.99; P < .05). There were no significant differences in time to or number of suicide attempts. In a post hoc analysis, however, MBCT-S significantly reduced the proportion of participants attempting suicide (P < .05). MBCT-S also reduced the proportion with a psychiatric hospitalization. No significant between-group differences emerged on any suicide-related factors. Conclusions: Adding MBCT-S to system-wide suicide prevention efforts produced mixed findings on the primary outcome (suicide events) and promising findings on other important outcomes (suicide attempts, psychiatric hospitalizations). MBCT-S should continue to be examined in future research.
AB - Objective: This study evaluated whether Mindfulness-Based Cognitive Therapy for Preventing Suicide Behavior (MBCT-S) effectively augmented treatment-as-usual enhanced for suicide prevention (eTAU). Methods: From December 2013 through March 2018, veterans (N = 140) at high risk for suicide were recruited mostly (88.6%) during a suicide-related inpatient admission and randomly assigned to either (1) eTAU augmented with MBCT-S or (2) eTAU only. MBCT-S began during inpatient treatment (2 individual sessions emphasizing safety planning) and continued post-discharge (8 group sessions emphasizing mindfulness skills and elaborated safety planning). Four follow-up evaluations occurred over 12 months, and primary outcomes were (1) time to suicide event and (2) number of suicide events. Secondary outcomes were time to and number of suicide attempts, proportion with acute psychiatric hospitalization, and change in suicide-related factors (eg, depression, hopelessness, suicidal ideation). Results: Relative to eTAU, MBCT-S did not significantly delay time to suicide event (hazard ratio = 0.86; 95% CI, 0.52-1.41; P = .54), but did reduce total number of suicide events (MBCT-S: 56 events; eTAU: 92 events; incident rate ratio = 0.59; 95% CI, 0.36-0.99; P < .05). There were no significant differences in time to or number of suicide attempts. In a post hoc analysis, however, MBCT-S significantly reduced the proportion of participants attempting suicide (P < .05). MBCT-S also reduced the proportion with a psychiatric hospitalization. No significant between-group differences emerged on any suicide-related factors. Conclusions: Adding MBCT-S to system-wide suicide prevention efforts produced mixed findings on the primary outcome (suicide events) and promising findings on other important outcomes (suicide attempts, psychiatric hospitalizations). MBCT-S should continue to be examined in future research.
UR - http://www.scopus.com/inward/record.url?scp=85123693007&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123693007&partnerID=8YFLogxK
U2 - 10.4088/JCP.20M13791
DO - 10.4088/JCP.20M13791
M3 - Article
C2 - 34464524
AN - SCOPUS:85123693007
SN - 0160-6689
VL - 82
JO - Journal of Clinical Psychiatry
JF - Journal of Clinical Psychiatry
IS - 5
M1 - 20M13791
ER -